Nautilus Advisors LLC Teva Pharmaceutical Industries LTD Transaction History
Nautilus Advisors LLC
- $136 Billion
- Q2 2025
A detailed history of Nautilus Advisors LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Nautilus Advisors LLC holds 11,925 shares of TEVA stock, worth $238,857. This represents 0.15% of its overall portfolio holdings.
Number of Shares
11,925
Previous 11,925
-0.0%
Holding current value
$238,857
Previous $183 Million
9.04%
% of portfolio
0.15%
Previous 0.15%
Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
655Shares Held
663MCall Options Held
30.1MPut Options Held
16.4M-
Black Rock Inc. New York, NY43MShares$861 Million0.02% of portfolio
-
Menora Mivtachim Holdings Ltd.38.5MShares$771 Million3.78% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.3MShares$768 Million36.86% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$757 Million5.98% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L337.8MShares$756 Million8.62% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $22.2B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...